Dermatology · Philadelphia, PA
NPI
1003201617
Since 2015
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
800 Spruce Street, 10th Floor
Philadelphia, PA, 19107
Phone (941) 718-8997
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,257 services
Medicare patients, 2024
530
Average age 72
Drug cost, 2024
$2.3M
1,704 prescriptions
Company payments, 2025
$149K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas K Mollanazar was code 17003 (destruction skin lesion), 811 times for 139 patients. In total Nicholas K Mollanazar billed 2,257 services in 55 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Facility | 811 | 139 | $1.48 | $1,204 |
| 11102 Skin Biopsy | Facility | 224 | 207 | $22.20 | $4,973 |
| 17000 Destruction Skin Lesion | Facility | 189 | 173 | $40.30 | $7,617 |
| 99214 Office E&M - Established | Facility | 175 | 143 | $67.62 | $12K |
| 99213 Office E&M - Established | Facility | 154 | 135 | $47.40 | $7,300 |
| 99203 Office E&M - New | Facility | 138 | 138 | $56.95 | $7,859 |
| 11103 Skin Biopsy | Facility | 115 | 74 | $16.89 | $1,942 |
| 99204 Office E&M - New | Facility | 115 | 115 | $95.05 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 113 | 95 | $12.49 | $1,411 |
| 17110 Destruction Skin Lesion | Facility | 22 | 18 | $46.39 | $1,021 |
| 17004 Destruction Skin Lesion | Facility | 20 | 19 | $75.20 | $1,504 |
| 11104 Skin Biopsy | Facility | 12 | 12 | $34.71 | $416 |
By year: 2022 $71K for 1,894 services; 2023 $65K for 2,086 services; 2024 $71K for 2,257 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas K Mollanazar prescribed most often to Medicare patients was Triamcinolone Acetonide, with 365 prescriptions and refills. In total Nicholas K Mollanazar wrote 1,704 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 365 | 418 | 213 | $5,687 |
| Clobetasol Propionate Generic | 329 | 348 | 160 | $20K |
| Dupixent Pen Dupilumab | 229 | 236 | 32 | $875K |
| Dupixent Syringe Dupilumab | 74 | 74 | Under 11 | $263K |
| Clindamycin Phosphate Generic | 74 | 74 | 29 | $3,051 |
| Ketoconazole Generic | 71 | 78 | 35 | $981 |
| Doxycycline Hyclate Generic | 62 | 73 | 43 | $1,136 |
| Gabapentin Generic | 34 | 46 | Under 11 | $585 |
| Acitretin Generic | 31 | 31 | Under 11 | $8,849 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 30 | 30 | 22 | $1,213 |
| Tremfya Guselkumab | 29 | 53 | Under 11 | $367K |
| Mupirocin Generic | 28 | 34 | 16 | $265 |
| Tacrolimus Generic | 26 | 31 | 13 | $5,411 |
| Nystatin Generic | 26 | 28 | Under 11 | $563 |
| Doxycycline Monohydrate Generic | 20 | 58 | 17 | $1,408 |
Brand drugs: 472 claims; generic drugs: 1,232 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas K Mollanazar $149K ($149K in general payments such as food, travel and fees) from 7 companies. The largest payer was Genzyme Corporation with $100K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.